We use privacy-friendly analytics. Read our privacy policy.DNT/GPC detected: tracking stays off.
Evidence-first comparison
Melatonin vs L-Theanine
Primary decision context: Sleep or wind-down decisions where circadian timing and relaxation evidence should not be treated as interchangeable.
Quick verdict
Evidence edge: Melatonin
Melatonin has the stronger profile-level evidence grade in the canonical records (A vs B). That is an overall evidence signal, not proof that it is better for every outcome.
Melatonin and L-theanine can both appear in sleep routines, but one is closely tied to circadian signaling while the other is usually discussed in calm and relaxation contexts. This comparison keeps their evidence, dose, safety, and formulation records distinct.
The table below is populated from each ingredient’s canonical runtime record. Missing fields stay visibly missing rather than being filled with mechanism-derived assumptions.
Choose Melatonin if…
•Its human-evidence summary directly addresses the outcome you are researching.
•Its studied dose and formulation context match the form you are actually evaluating.
•You have reviewed its documented safety and interaction constraints rather than choosing on marketing claims alone.
Choose L-Theanine if…
•Its human-evidence summary directly addresses the outcome you are researching.
•Its studied dose and formulation context match the form you are actually evaluating.
•You have reviewed its documented safety and interaction constraints rather than choosing on marketing claims alone.
Neither may be appropriate if…
The comparison itself does not clear the decision bar
•Neither option has adequate human outcome evidence for the actual decision context: Sleep or wind-down decisions where circadian timing and relaxation evidence should not be treated as interchangeable.
•The available comparison is driven mainly by mechanism, chemistry, or marketing rather than replicated human outcomes.
•A contraindication, medication interaction, pregnancy concern, or other safety constraint makes unsupervised use inappropriate.
•The relevant studied formulation or dose is materially different from the product or form being considered.
Melatonin vs L-Theanine: evidence, dose, and safety
This table scrolls horizontally on small screens. Use Tab to focus the table region, then scroll with arrow keys or touch.
Melatonin vs L-Theanine: evidence, dose, and safety
Dimension
Melatonin
L-Theanine
Evidence strength
A
B
Human evidence
Not available in the canonical record.
Not available in the canonical record.
Studied dose / dose context
Dose-response meta-analysis suggested sleep effects peaking around 4 mg/day and timing about 3 hours before desired bedtime in that analysis; common practice varies. | Oral melatonin; immediate vs prolonged-release and timing should be separated.
powder or capsule
Forms / preparation
Not available in the canonical record.
Not available in the canonical record.
Safety
Safety evidence: higher-dose adult trials found more drowsiness, headache, and dizziness without a detected serious-adverse-event increase, but reporting and long-term evidence were limited. Driving, concurrent sedatives, pregnancy, breastfeeding, pediatric use, and chronic use require individualized review.
Safety evidence: a systematic review of short-term trials reported no serious adverse events, but study populations and dosing varied. Long-term use, pregnancy, breastfeeding, surgery, organ impairment, and clinically significant medication interactions remain insufficiently characterized.
Dose-response meta-analysis suggested sleep effects peaking around 4 mg/day and timing about 3 hours before desired bedtime in that analysis; common practice varies. | Oral melatonin; immediate vs prolonged-release and timing should be separated.
Forms / preparation
Not available in the canonical record.
Safety
Safety evidence: higher-dose adult trials found more drowsiness, headache, and dizziness without a detected serious-adverse-event increase, but reporting and long-term evidence were limited. Driving, concurrent sedatives, pregnancy, breastfeeding, pediatric use, and chronic use require individualized review.
Safety evidence: a systematic review of short-term trials reported no serious adverse events, but study populations and dosing varied. Long-term use, pregnancy, breastfeeding, surgery, organ impairment, and clinically significant medication interactions remain insufficiently characterized.
Dose-response meta-analysis indicates melatonin effects depend heavily on timing and dose; adult chronic insomnia evidence is nuanced and not uniformly positive.
Read the full profile →Mechanism differences are shown as mechanism context, not as proof of different health benefits. Comparison conclusions should follow human outcome evidence, safety, dose, and formulation data where those fields are available.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.